Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search



You are here Staff

Professor Vincent Maher
Clinical Associate Professor, Clinical Medicine

Biography

Vincent Maher is a Clinical Associate Professor at Trinity College Dublin(TCD), Consultant Cardiologist and Director of Chronic Cardiovascular Disease at Tallaght University Hospital, Dublin. He received his MB BCh BAO degrees from University College Galway, Doctorate in Medicine from TCD and Fellowships from the Royal College of Physicians in Ireland, American College of Cardiology and European Society of Cardiology. He has been a life long advocate for heart disease prevention and reversal, working as Medical Director of the Irish Heart Foundation, Co founder of the National HeartWatch programme, Founder of the Irish Atherosclerosis/Angiology Society, President of the Irish Cardiac Rehabilitation Society, Chairman of the Irish Health Promoting Hospitals and Founder and current Chairman of the Irish Hyperlipidaemia Network. He set up Ireland's First Advanced Lipid Management and Research ALMAR Centre at Tallaght University Hospital. He has published numerous papers, book chapters and booklets related to heart disease prevention through intensive risk factor management, particularly lipid disorders and hypertension. He lectures regularly to students, medical personnel and lay audiences both nationally and internationally. His main research relates to the determinants of cardiovascular disease change with a focus on lipids, vascular stiffness and heart inefficiency. He is married, has four grown up daughters, tries to learn French, plays guitar, loves painting, cycles and is a life long supporter of Manchester City Football Club.

Publications and Further Research Outputs

Peer-Reviewed Publications

E Egom R Pharithi S Hesse N Starr R Armstrong .Habitha M Sulaiman, K Gazdikova I Mozos,· M Caprnda,· P Kubatka,· P KruzliakB Khan· LGaspar· ViMG.Maher, Latest Update on Lipid Management, High Blood Pressure & Cardiovascular Prevention , 10, (1), 2019 Journal Article, 2019

Ruth Agar Vincent Maher, Lipid, Lipoprotein and Cholesterol Management in clinical practice, Nursing in General Practice, 6, (1), 2018, p45 - 48 Journal Article, 2018

Agar, R., Markham, C., Prendergast, M., Canning, R., Maher, E., Finn, C., Sammon, N., Fall, S., Fallon, N., Hanrahan, E., King, L., Maher, V., A snapshot of lipid levels in the Republic of Ireland in 2017, Irish Journal of Medical Science, 2018, p1-7 Journal Article, 2018

N Fallon, P McGeary, G McKee, MB Quirke, N Flynn, R O'Mahony, S.Malone, V Maher, C Finn, The effectiveness of cardiac rehabilitation in improving quality of life in patients following a cardiac diagnosis, The 37th RCSI Annual International Nursing & Midwifery Research and Education Conference 2018, 28 Feb-1 Mar 2018, 2018 Meeting Abstract, 2018

N Fallon, P McGeary, G McKee, MB Quirke, N Flynn, R O'Mahony, V Jones, S Tierney, B Egan, V Maher, C Finn, U McCrystal, C O'Connelll, Peripheral arterial disease risk assessment & rehabilitation programme, The 37th RCSI Annual International Nursing & Midwifery Research and Education Conference 2018, Dublin, Ireland, 28 Feb-1 Mar 2018, 2018 Meeting Abstract, 2018

Vallejo-Vaz, A.J., Marco, M.D., Kastelein, J.J.P., Watts, G.F.,, Maher, V., ..., Agar, R., Boran, G., Colwell, N., Crowley, V., Durkin, M., Griffin, D., Kelly, M., Rakovac-Tisdall, A., , Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), Atherosclerosis, 277, 2018, p234-255 Journal Article, 2018

Egom, E.E., Maher, V., El Hiani, Y., Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure, International Journal of Cardiology, 2018 Journal Article, 2018

Caroline Finn, Vincent Maher, Gabrielle McKee , Using regression models to identify the current sociodemographic, clinical and logistic factors that influence enrolment and attendance in Cardiac Rehabilitation, European Journal of Preventative Cardiology, 2018 Journal Article, 2018

Egom, E.E., Pharithi, R.B., Shiwani, H.A., Khan, B., Kruzliak, P., El-Hiani, Y., Maher, V., Time to redefine body mass index categories in chronic diseases? Spotlight on obesity paradox, International Journal of Food Sciences and Nutrition, 69, (5), 2018, p513-523 Journal Article, 2018

Egom, E.E., Shiwani, H.A., Pharithi, R.B., Canning, R., Khan, B., Hiani, Y.E., Maher, V., Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: Spotlight on sphingosine-1-phosphate/serum amyloid A ratio, Clinical and Experimental Pharmacology and Physiology, 45, (4), 2018, p319-325 Journal Article, 2018

Egom EE, Fitzgerald R, Canning R, Pharithi RB, Murphy C, Maher V., Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry., International journal of molecular sciences, 18, (8), 2017 Journal Article, 2017 DOI

Egom, E.E., Feridooni, T., Pharithi, R.B., Khan, B., Shiwani, H.A., Maher, V., El Hiani, Y., Pasumarthi, K.B.S., Ribama, H.A., A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure, Biomedicine and Pharmacotherapy, 93, 2017, p1144-1150 Journal Article, 2017

Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, El Hiani Y, Rose RA, Pasumarthi KB, Ribama HA, New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease., International Journal of Physiology, Pathophysiology and Pharmacology, 2017 Journal Article, 2017

Shiwani HA, Pharithi RB, Khan B, Egom CB, Kruzliak P, Maher V, Egom EE., An update on the 2014 Ebola outbreak in Western Africa., Asian Pacific journal of tropical medicine, 10, (1), 2017, p6-10 Journal Article, 2017 DOI

Eroume-A Egom, E., Feridooni, T., Pharithi, R.B., Khan, B., Shiwani, H.A., Maher, V., El Hiani, Y., Rose, R.A., Pasumarthi, K.B.S., Ribama, H.A., Erratum to: New insights and new hope for pulmonary arterial hypertension: Natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease (Int J Physiol Pathophysiol Pharmacol, (2017), 9, 4, (112-118)), International Journal of Physiology, Pathophysiology and Pharmacology, 9, (5), 2017, p157 Journal Article, 2017

Vallejo-Vaz, A.J., Akram, A., Kondapally Seshasai, S.R., Cole, D., Watts, G.F., Hovingh, G.K., Kastelein, J.J.P., Mata, P., Raal, F.J., Santos, R.D., Soran, H., Freiberger, T., Abifadel, M., Aguilar-Salinas, C.A., Alnouri, F., Alonso, R., Al-Rasadi, K., Banach, M., Bogsrud, M.P., Bourbon, M., Bruckert, E., Car, J., Ceska, R., Corral, P., Descamps, O., Dieplinger, H., Do, C.T., Durst, R., Ezhov, M.V., Fras, Z., Gaita, D., Gaspar, I.M., Genest, J., Harada-Shiba, M., Jiang, L., Kayikcioglu, M., Lam, C.S.P., Latkovskis, G., Laufs, U., Liberopoulos, E., Lin, J., Lin, N., Maher, V., Majano, N., Marais, A.D., März, W., Mirrakhimov, E., Miserez, A.R., Mitchenko, O., Nawawi, H., Nilsson, L., Nordestgaard, B.G., Paragh, G., Petrulioniene, Z., Pojskic, B., Reiner, Ž., Sahebkar, A., Santos, L.E., Schunkert, H., Shehab, A., Slimane, M.N., Stoll, M., Su, T.-C., Susekov, A., Tilney, M., Tomlinson, B., Tselepis, A.D., Vohnout, B., Widén, E., Yamashita, S., Catapano, A.L., Ray, K.K., Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Atherosclerosis Supplements, 22, 2016, p1-32 Journal Article, 2016

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner ", Riccardi G, ESC Scientific Document Group ( V Maher), 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias., European heart journal, 2016 Journal Article, 2016

Moran, D., Buckley, A., Daly, K., Meaney, B., Curtin, R., O'Neill, J.O., Colwell, N., Mahon, N., Murphy, N., O 'Hanlon, R., Daly, C., Adam, B.M., Donald, K.M., Maher, V., Erratum: Heart rate awareness in patients with chronic stable heart failure. A multi-center observational study (International Journal of Cardiology (2014) 177: 2 (380-384) DOI: 10.1016/j.ijcard.2014.08.119), International Journal of Cardiology, 210, 2016, p180 Journal Article, 2016

Egom, E.E.-A., Bae, J.S.H., Capel, R., Richards, M., Ke, Y., Pharithi, R.B., Maher, V., Kruzliak, P., Lei, M., Effect of sphingosine-1-phosphate on L-type calcium current and Ca2+ transient in rat ventricular myocytes, Molecular and Cellular Biochemistry, 419, (1-2), 2016, p83-92 Journal Article, 2016

Cooney, M., Cooney, M.-T., Maher, V., Khan, B., Leong, T., Graham, I., Improvement in the estimation of cardiovascular risk by carotid intima-medial thickness: A report from the Dublin Cardiohealth station study, Preventive Medicine Reports, 2, 2015, p725-729 Journal Article, 2015

Dillinger, J.-G., Maher, V., Vitale, C., Henry, P., Logeart, D., Silberman, S.M., Allée, G., Levy, B.I., Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease, Hypertension, 66, (6), 2015, p1138-1144 Journal Article, 2015

Ananey, O.M., McLoughlin, B., Leonard, A., Maher, L., Gaffney, P., Boran, G., Maher, V., Inverse relationship between physical activity, adiposity, and arterial stiffness in healthy middle-aged subjects, Journal of Physical Activity and Health, 12, (12), 2015, p1576-1581 Journal Article, 2015

Murphy TM, Waterhouse DF, Maher V, O'Hanlon R, CMR detection of membraneous ventricular septal aneurysm causing ventricular tachycardia., Diagnostic and interventional imaging, 2015 Journal Article, 2015

O'Doherty, V., Carr, A., McGrann, A., O'Neill, J.O., Dinan, S., Graham, I., Maher, V., A Controlled Evaluation of Mindfulness-Based Cognitive Therapy for Patients with Coronary Heart Disease and Depression, Mindfulness, 6, (3), 2015, p405-416 Journal Article, 2015

Sattar, N.A., Ginsberg, H., Ray, K., Chapman, M.J., Arca, M., Averna, M., Betteridge, D.J., Bhatnagar, D., Bilianou, E., Carmena, R., "eška, R., Corsini, A., Erbel, R., Flynn, P.D., Garcia-Moll, X., Gumprecht, J., Ishibashi, S., Jambart, S., Kastelein, J.J.P., Maher, V., Marques da Silva, P., Masana, L., Odawara, M., Pedersen, T.R., Rotella, C.M., Salti, I., Teramoto, T., Tokgozoglu, L., Toth, P.P., Valensi, P., Vergès, B., The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice, Atherosclerosis Supplements, 15, (1), 2014, p1-15 Journal Article, 2014

Mac Ananey Oscar, Mellotte Greg, Maher Vincent, Comparison of semi-automated and manual measurements of carotid intima-media thickening , BioMed research international , 2014 , 2014 Journal Article, 2014 TARA - Full Text

Moran, D., Buckley, A., Daly, K., Meaney, B., Curtin, R., O'Neill, J.O., Colwell, N., Mahon, N., Murphy, N., O'Hanlon, R., Daly, C., Mc Adam, B., Mc Donald, K., Maher, V., Heart rate awareness in patients with chronic stable heart failure. A multi-center observational study, International Journal of Cardiology, 177, (2), 2014, p380-384 Journal Article, 2014

Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, AleCardio Investigators, Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial., JAMA, 2014 Journal Article, 2014

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, SIGNIFY Investigators, Ivabradine in stable coronary artery disease without clinical heart failure., The New England journal of medicine, 2014 Journal Article, 2014

Crowley RK, Broderick D, O'Shea T, Boran G, Maher V, Crowther S, Gibney J, Conlon KC, Sherlock M, Spironolactone interference in the immunoassay of androstenedione in a patient with a cortisol secreting adrenal adenoma., Clinical Endocrinology, 81, (4), 2014, p629 - 630 Journal Article, 2014

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R, ONTARGET Investigators, Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus., JAMA internal medicine, 2013 Journal Article, 2013

Dunne, M., Mac Ananey, O., Markham, C., Maher, V., Lipid targets in clinical practice: Successes, failures and lessons to be learned, Irish Journal of Medical Science, 182, (4), 2013, p673-678 Journal Article, 2013

O'Kane, M.J., Menown, I.B., Graham, I., Maher, V., Tomkin, G., Nicholls, P., Graham, C., The detection of heterozygous familial hypercholesterolemia in Ireland, Advances in Therapy, 29, (5), 2012, p456-463 Journal Article, 2012

Desmond A, Stanton A, Maher V, Crean P, Feely J, Sullivan P, A survey of patients' attitudes to clinical research., Irish medical journal, 2011 Journal Article, 2011

Rehabilitation of the patient with Coronary Heart Disease Hurst's 13th Edition. in, editor(s)Fuster Walsh Harrington , Hursts The Heart Edition: 13th Chapter:, USA, McGraw Hill Medical, 2010, pp1513 - 1530, [Graham I, Ingram S, Fallon N, Leong T, Gormely J, O Doherty V, Maher V, Benson S. ] Book Chapter, 2010

Murtagh, G., Maher, V., Factors affecting thrombosis in women, Thrombosis: Causes, Treatment and Prevention, 2010, p119-130 Journal Article, 2010

E Cronin V Maher, Clopidogrel and proton pump inhibitors- another cause for concern in cardiovascular pharmacology ? , Cardio Diabetes , 2, (3), 2009, p12 - 13 Journal Article, 2009

Menown, I.B.A., Murtagh, G., Maher, V., Cooney, M.T., Graham, I.M., Tomkin, G., Dyslipidemia therapy update: The importance of full lipid profile assessment, Advances in Therapy, 26, (7), 2009, p711-718 Journal Article, 2009

Maher, V., O'Dowd, M., Carey, M., Markham, C., Byrne, A., Hand, E., Mc Inerney, D., Association of central obesity with early Carotid intima-media thickening is independent of that from other risk factors, International Journal of Obesity, 33, (1), 2009, p136-143 Journal Article, 2009

Fox KA, Després JP, Richard AJ, Brette S, Deanfield JE, IDEA Steering Committee and National Co-ordinators, Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries., European heart journal, 2009 Journal Article, 2009

Maher, V.M.G., Kitano, Y., Neuwirth, C., Davies, G.J., Maseri, A., Thompson, G.R., Andreotti, F., Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis, Journal of Thrombosis and Thrombolysis, 28, (2), 2009, p166-172 Journal Article, 2009

Rehabilitation of the patient with Coronary Heart Disease in, editor(s)Fuster V, O'Rourke R, Walsh R.A, Poole-Wilson P. , Hurst's The Heart, New York, Mc Graw Hill , 2008, pp1529 - 1551, [Graham I, ingram S, fallon N, leong T, gormley J, O'Doherty V, Maher V, Benson S] Book Chapter, 2008

, Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial., Lancet (London, England), 2008 Journal Article, 2008

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C, Telmisartan, ramipril, or both in patients at high risk for vascular events., The New England journal of medicine, 2008 Journal Article, 2008

Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators, Irbesartan in patients with heart failure and preserved ejection fraction., The New England journal of medicine, 2008 Journal Article, 2008

Vincent Maher, Emer O'Sullivan, Vivien Reid, Donal O 'Shea, Brian Maurer, Ian Graham, Sinead McCarthy, Celine Murrin, Edna Roche, Michael Conway, The Irish Heart Foundation Nutrition Guidelines for Heart Health, 1, , Irish Heart Foundation, june, 2007, p1 - 25 Report, 2007

Carey, M., Markham, C., Gaffney, P., Boran, G., Maher, V., Validation of a point of care lipid analyser using a hospital based reference laboratory, Irish Journal of Medical Science, 175, (4), 2006, p30-35 Journal Article, 2006

Ingram S, Maher V, Bennett K, Gormley J., The effect of cardiopulmonary resuscitation training on psychological variables of cardiac rehabilitation patients, Resuscitation, 71, (1), 2006, p89 - 96 Journal Article, 2006

Maher V.M.G. Riordan A O , The health promoting hospitals concept., Journal of Health Gain, 2, 2001, p14 - 16 Journal Article, 2001

C O Brien, J Peters, P Murphy, V Maher, M O Muirahurtha, M Mulvihill, A Moran, , I Perry, L Hennessy, C Barry, T Dorley , Irish Heart Foundation Position Statement on Physical Activity , Irish Heart Foundation , 2000, p1 - 25 Report, 2000

Brown, B.G., Zambon, A., Poulin, D., Rocha, A., Maher, V.M.G., Davis, J.W., Albers, J.J., Brunzell, J.D., Use of niacin, statins, and resins in patients with combined hyperlipidemia, American Journal of Cardiology, 81, (4 A), 1998, p52B-59B Journal Article, 1998

Sun XM, Patel DD, Knight BL, Soutar AK. V Maher, Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study Group., Atherosclerosis, 136, (1), 1998, p175-185 Journal Article, 1998 DOI

Brown, B.G., Bardsley, J., Poulin, D., Hillger, L.A., Dowdy, A., Maher, V.M.G., Zhao, X.-Q., Albers, J.J., Knopp, R.H., Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidema and coronary artery disease, American Journal of Cardiology, 80, (2), 1997, p111-115 Journal Article, 1997

Vos J1, de Feyter PJ, Kingma JH, Emanuelsson H, Legrand V, Winkelmann B, Dumont JM, Simoons LM. V Maher The Multicenter Anti-Atheroma Study (MAAS) Investigators., Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. , Eur Heart J. , 18, (7), 1997, p1081 - 1089 Journal Article, 1997

V Maher, Atherosclerotic plaque stabilization: A strategy for managing coronary artery disease., J Royal Colleges of Physicians & Surgeons of Ireland, 26, 1997, p35 - 38 Journal Article, 1997

Maher, V.M.G., Brown, B.G., Elevated Lipoprotein(a) and Premature Coronary Heart Disease, JAMA: The Journal of the American Medical Association, 277, (3), 1997, p209 Journal Article, 1997

Maher, V., Sinfuego, J., Chao, P., Parekh, J., Primary prevention of coronary heart disease. What has WOSCOPS told us and what questions remain?, Drugs, 54, (1), 1997, p1-8 Journal Article, 1997

Sidhu, P.S., Naoumova, R.P., Maher, V.M.G., MacSweeney, J.E., Neuwirth, C.K.Y., Hollyer, J.S., Thompson, G.R., Erratum: The extracranial carotid artery in familial hypercholesterolaemia: Relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease (Journal of Cardiovascular Risk (1996) 3 (61-67)), Journal of Cardiovascular Risk, 3, (4), 1996, p424 Journal Article, 1996

Maher, V.M.G., Thompson, G.R., LDL apheresis: Role in the treatment of atherosclerosis, Journal of the Irish Colleges of Physicians and Surgeons, 25, (2), 1996, p96-99 Journal Article, 1996

Familial Atherosclerosis Treatment Study. in, Bruschke AVG, Reiber JHC, Lie KI, Wellens HJJ Kluwer , Developments in Cardiovascular Medicine "Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis, Academic Publishers, London, 1996, pp100 - 104, [V Maher] Book Chapter, 1996

Sidhu, P.S., Naoumova, R.P., Maher, V.M.G., Macsweeney, J.E., Neuwirth, C.K.Y., Hollyer, J.S., Thompson, G.R., The extracranial carotid artery in familial hypercholesterolemia: Relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease, European Journal of Cardiovascular Prevention & Rehabilitation, 3, (1), 1996, p61-67 Journal Article, 1996

Maher VM, Coronary atherosclerosis stabilization: an achievable goal., Atherosclerosis, 1995 Journal Article, 1995

Thompson, G.R., Maher, V.M.G., Kitano, Y., Neuwirth, C., Maher, V.M.G., Davies, G., Matthews, S., Shortt, M.B., Rees, A., Mir, A., Henderson, A., Prescott, R.J., de Feyter, P., Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis, The Lancet, 345, (8953), 1995, p811-816 Journal Article, 1995

Maher, V.M.G., Greg Brown, B., Marcovina, S.M., Hillger, L.A., Zhao, X.-Q., Albers, J.J., Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a), JAMA: The Journal of the American Medical Association, 274, (22), 1995, p1771-1774 Journal Article, 1995

Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ, Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)., JAMA, 1995 Journal Article, 1995

Maher, V.M.G., Brown, B.G., Lipoprotein (a) and coronary heart disease, Current Opinion in Lipidology, 6, (4), 1995, p229-235 Journal Article, 1995

Maher, V.M.G., Gallagher, J.J., Thompson, G.R., Myant, N.B., Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?, Atherosclerosis, 118, (1), 1995, p105-110 Journal Article, 1995

HDLc as a therapeutic target in coronary disease: Current concepts and future directions in, editor(s)Assmann G , HDL deficiency and Atherosclerosis, Dordrecht, , Kluwer Academic Publishers, Dordrecht, , 1995, pp29 - 42, [Brown BG, Zhao X-Q, Maher VMG, Chait A, Cheung M, Fisher LD, Albers J.] Book Chapter, 1995

MF OLIVERPJ DEFEYTER Jacobus Lubsen...V Maher... FJ VANDALEN, EFFECT OF SIMVASTATIN ON CORONARY ATHEROMA - THE MULTICENTER ANTI-ATHEROMA STUDY (MAAS), The Lancet, 344, (8923), 1994, p633 - 638 Journal Article, 1994

Brown, B.G., Maher, V.M., Reversal of coronary heart disease by lipid-lowering therapy. Observations and pathological mechanisms., Circulation, 89, (6), 1994, p2928-2933 Journal Article, 1994

Dumont JM. (V Maher MAAS Investigator), Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study , Control Clin Trials., 14, (3), 1993, p209 - 228 Journal Article, 1993

Maher, V.M.G., Gallagher, J.J., Myant, N.B., The binding of very low density lipoprotein remnants to the low density lipoprotein receptor in familial defective apolipoprotein B-100, Atherosclerosis, 102, (1), 1993, p51-61 Journal Article, 1993

LDL Apheresis-State of the art. in, editor(s)W.O. Richter) , Treatment of severe dyslipoproteinemia in the prevention of coronary heart disease , Karger, Munchen, Karger, 1992, pp319 - 326, [Kitano Y., Neuwirth C., Maher V., Thompson G.R. ] Book Chapter, 1992

Maher, VincentM.G., Gallagher, JohnJ., Thompson, GilbertR., Myant, NicholasB., Cholesterol-lowering drugs in familial defective apolipoprotein B-100, The Lancet, 339, (8796), 1992, p811 Journal Article, 1992

Maher VM, Trainer PJ, Scoppola A, Anderson JV, Thompson GR, Besser GM, Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia., The Quarterly journal of medicine, 1992 Journal Article, 1992

Maher, V.M.G., Kitano, Y., Neuwirth, C., Gallagher, J.J., Thompson, G.R., Myant, N.B., Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100, Atherosclerosis, 95, (2-3), 1992, p231-234 Journal Article, 1992

Maher, V.M.G., Gallagher, J.J., Thompson, G.R., Myant, N.B., Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100, Atherosclerosis, 91, (1-2), 1991, p73-76 Journal Article, 1991

Scoppola A, Maher VM, Thompson GR, Rendell NB, Taylor GW, Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry., Journal of lipid research, 1991 Journal Article, 1991

Owens, D., Maher, V., Collins, P., Johnson, A., Tomkin, G., Cellular cholesterol regulation - A defect in the Type 2 (non-insulin-dependent) diabetic patient in poor metabolic control, Diabetologia, 33, (2), 1990, p93-99 Journal Article, 1990

V Maher, Atherosclerosis: cell biology and lipoproteins, Current Opinion in Lipidology , 1, (3), 1990, p294 - 297 Journal Article, 1990

Maher, V.M.G., Thompson, G.R., Analysis of evidence from cholesterol-lowering and regression trials, Journal of Drug Development, Supplement, 3, (1), 1990, p199-203 Journal Article, 1990

Maher VM, Thompson GR, HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin., The Quarterly journal of medicine, 1990 Journal Article, 1990

Maher, V.M.G., Pappu, A., Illingworth, D.R., Thompson, G.R., PLASMA MEVALONATE RESPONSE IN LOVASTATIN-RELATED MYOPATHY, The Lancet, 334, (8671), 1989, p1098 Journal Article, 1989

Devery R., Maher V., Mulhern M., Collins P., Johnson A., Tomkin G., 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in mononuclear leucocytes of diabetic patients, Biochemical Society Transactions, 15, 1987, p255 - 256 Journal Article, 1987

Fitzgerald MJ, Fitzgerald M, Brophy J, Lin E, Maher V, Purpose-made models in anatomical teaching., The Journal of audiovisual media in medicine, 1979 Journal Article, 1979

Non-Peer-Reviewed Publications

E Egom, V Maher E Harris, Latest update on lipid management , Forum, 6, (1), 2018, p24 - 28 Journal Article, 2018

C Murphy V Maher, Understanding, Angiography Angioplasty and Cardiac catheterisation. Revised edition IHF information book, 2nd, Irish Heart Foundation , 2013 Book, 2013

C Daly V Maher, Myocardial Infarction and its management IHF information book Revised edition. , 2nd, 2011 Book, 2011

K Kirwan V Maher, Step by step through Angina , 2004 Book, 2004

C Daly V Maher, Step by step through Myocardial Infarction, 1st, Irish Heart Foundation , 2003, 1 - 26pp Book, 2003

C Murphy V Maher, Step by step through Cardiac Catheterization and Angioplasty , 1st, Irish Heart Foundation , 2003, 1 - 23pp Book, 2003

V Maher, Treatment of hyperlipidaemia in pre-menopausal women , HeartWise, 5 , (1), 2002, p18 - 20 Journal Article, 2002

Mary Codd ( Council on Womens Heart Disease V Maher) , Fifty years of heart disease in Ireland 1950 -1999. , 1st, 2001, 1 - 16pp Book, 2001

V Maher M Carey C Markham, Considerations in blood pressure management , Heart Wise, 4, (3), 2001, p35 - 39 Journal Article, 2001

V Maher, Looking beyond Coronary Artery Stenoses , Heart Wise, 4, (2), 2001, p40 - 42 Journal Article, 2001

V Maher, Suggested management of raised blood lipids. , MIMS, 1989 Journal Article, 1989

Research Expertise

Projects

  • Title
    • Determinants of Vascular ageing
  • Summary
    • Goal: Longitudinal study to examine the factors that are associated with progressive vascular ageing as measured by vascular stiffness, vascular distensibility, carotid intima media thickening and ventricular diastolic function. Risk factors , anthropometric measurements, body composition and chemical measurements are being made every 5 years on a population of 232 previously healthy , life-long never smokers with initial normal cardiac risk factors.
  • Funding Agency
    • Clinical trial funds
  • Date From
    • 2012
  • Date To
    • 2022
  • Title
    • Association of obesity with heart failure survival. AdipoHeart Study
  • Summary
    • This is a longitudinal study to examine the association of diet, activity levels, functional capacity, vascular stiffness, anthropometric measurements, body composition and psychological status on outcomes in a population of 400 patients with chronic stable heart failure.
  • Funding Agency
    • Clinical trial funds plus fund raising
  • Date From
    • 2016
  • Date To
    • 2021

Keywords

Arterial Stiffness; ARTERIAL-HYPERTENSION; BLOOD-LIPIDS; CALCIFICATION; CARDIAC REHABILITATION; Cardiovascular regulation and hypertension; CHOLESTEROL METABOLISM; CHOLESTEROL-LOWERING DIETS; CHRONIC HEART-FAILURE; FAMILIAL HYPERCHOLESTEROLEMIA; LIPOPROTEIN CHOLESTEROL; Metabolic syndrome & diabetes; SERUM-LIPIDS

Recognition

Representations

National Lead on European Atherosclerosis Society FH Steering Committee 2016

Chairman of Irish Lipid Network 2016

Treasurer Irish Cardiac Society 2017

Regional Director Of Heart failure Services Dublin Mid Leinster 2010 - present

President of the Irish Hyperlipidaemia Association 2005 to 2007

President of the Irish Association of Cardiac Rehabilitation 2006 to 2008

Vice President of the Irish Association of Cardiac rehabilitation 2004

Board Member ASH Ireland 2000

Medical Director of the Irish Heart Foundation 1998

Chairman Irish Health Promoting Hospital Network 1999

Founder of the Irish Angiology Society 1998

Member KOWA Global Advisory Board on Lipid Management 2010

National and International Lectures 1998

Awards and Honours

Clinical Associate Physician Award NIH 10th Recipient UWMC 1994

Memberships

Member of Irish Cardiac Society 1998 – 2019

Member of European Atherosclerosis Society 2012 – 2019

Member of EAS FH Steering Committee 2016 – 2019

Honorary Life Member of IACR 2017 – 2019

Fellow of European Society of Cardiology 2010 – 2019

Fellow of the American College of Cardiology 2012 – 2019